20 years of Cure Parkinson's
We’re here for the cure! This year marks 20 years since Cure Parkinson’s was founded by four people living with Parkinson’s who felt that nobody was taking a cure seriously enough and that there was an urgent need for a focused approach to curative research...
Learn more
Cure Parkinson’s Patron Mike Tindall and Trustee Lyndsey Isaacs on BBC Breakfast
In this poignant film created by BBC Breakfast, which aired on 16 April, Mike Tindall spoke openly with his parents about how his father Philip’s Parkinson’s diagnosis has impacted the family. Cure Parkinson’s Trustee Lyndsey Isaacs also spoke to BBC Breakfast’s Dan Walker about Parkinson’s,…
Cure Parkinson’s Cure Collective is three years old
The Cure Collective is a group of like-minded individuals committed to help drive forward the quest to find a cure for Parkinson’s. Each member pledges to support Cure Parkinson’s with a minimum annual donation of £5,000.
Webinar – Genetic markers and the progression of Parkinson’s
Presented by the Journal of Parkinson’s Disease, Cure Parkinson’s and Van Andel Institute. This webinar discusses recent publications around the theme of genetic markers and the progression of Parkinson’s. The panel, chaired by Van Andel Institute’s Professor Patrik Brundin, comprises: Professor Mark Cookson from NIH;…
Further funding announced for clinical studies and data investigation
After a year of disruption, clinical research has now restarted and lab-based research is getting back on track. Cure Parkinson’s is delighted to report that it is investing significant funds into research in the first quarter of 2021.
An important ruling for aducanumab
On the 7th June, the US FDA held a special meeting and approved an experimental drug called aducanumab for the treatment of Alzheimer’s. This decision represents a major milestone for neurodegenerative research.